← Back to patent-cliff list
CAS 175481-36-4
(R)-2-acetamido-N-benzyl-3-methoxypropionamide
Codes: Lacosamide
Application context (from source-drug indications)
Tonic-clonic seizureLacosamideEpilepsyLacosamidePartial-onset seizureLacosamideSeizureLacosamide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lacosamide | Tier B — Position early | 2028 |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl (R)-1-((S)-1-phenylethyl)aziridine-2-carboxylate→ethyl O-methyl-N-((S)-1-phenylethyl)-D-serinate→ethyl N-acetyl-O-methyl-D-serinate→(R)-2-acetamido-N-benzyl-3-methoxypropionamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.